Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P40
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -14.85% |
| Q2 2025 | 33.40% |
| Q1 2025 | -46.98% |
| Q4 2024 | -72.42% |
| Q3 2024 | 79.20% |
| Q2 2024 | -151.31% |
| Q1 2024 | -34.46% |
| Q4 2023 | -36.91% |
| Q3 2023 | -9.13% |
| Q2 2023 | 56.90% |
| Q1 2023 | -105.03% |
| Q4 2022 | 17.07% |
| Q3 2022 | 53.13% |
| Q2 2022 | 25.64% |
| Q1 2022 | 7.14% |
| Q4 2021 | -8.61% |
| Q3 2021 | 0.49% |
| Q2 2021 | 6.56% |
| Q1 2021 | -11.80% |
| Q4 2020 | 4.84% |
| Q3 2020 | -19.93% |
| Q2 2020 | -2.31% |
| Q1 2020 | -37.91% |
| Q4 2019 | -22.52% |
| Q3 2019 | -10.38% |
| Q2 2019 | -57.61% |
| Q1 2019 | -58.12% |
| Q4 2018 | -33.68% |
| Q3 2018 | -8.74% |
| Q2 2018 | 4.24% |
| Q1 2018 | 0.00% |